Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers
Created: 2025-07-07 16:06:15 UTC

📌 Biotech Stock News 7/7 @ Open 🧬 📰

$COGT XX% Topline Results from SUMMIT Trial
$KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema
$FBIO X% Granted Orphan Drug Designation for CAR T-cells
$COLL X% $150M Share Repurchase Program
$LXEO X% Breakthrough Therapy Designation for LX2006
$ALUR X% Submission of PMA and Study Analyses

$URGN X% Completion of Ph3 UTOPIA Trial
$ALC X% Acquires LumiThera and Asset for Wet AMD Treatment
$BSX X% FDA Approval for Expanded Labeling

$NTRA -X% Data on Tissue-Free MRD Assay
$DNLI -X% FDA Acceptance and Priority Review for BLA
$NRIX -X% Orphan Drug Designation for Bexobrutideg
$LENZ -X% License and Commercialization Agreement for LNZ100
$AGEN -X% Two-Year Survival Data in CRC
$APGE -XX% 16-Week Data from Ph2 Trial
$JSPR -XX% Clinical Data Update on Briquilimab
See image for more details. 📸

$APGE down after release of 16-wk Ph2 data. See post from @BowTiedBiotech for more info 👀


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942253838402289849/c:line.svg)

**Related Topics**
[money](/topic/money)
[Sentiment](/topic/sentiment)
[$urgn](/topic/$urgn)
[$alur](/topic/$alur)
[breakthrough](/topic/breakthrough)
[$lxeo](/topic/$lxeo)
[$150m](/topic/$150m)
[$coll](/topic/$coll)

[Post Link](https://x.com/BiopharmIQ/status/1942253838402289849)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BiopharmIQ Avatar BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers Created: 2025-07-07 16:06:15 UTC

📌 Biotech Stock News 7/7 @ Open 🧬 📰

$COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses

$URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling

$NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -X% Orphan Drug Designation for Bexobrutideg $LENZ -X% License and Commercialization Agreement for LNZ100 $AGEN -X% Two-Year Survival Data in CRC $APGE -XX% 16-Week Data from Ph2 Trial $JSPR -XX% Clinical Data Update on Briquilimab See image for more details. 📸

$APGE down after release of 16-wk Ph2 data. See post from @BowTiedBiotech for more info 👀

XXXXX engagements

Engagements Line Chart

Related Topics money Sentiment $urgn $alur breakthrough $lxeo $150m $coll

Post Link

post/tweet::1942253838402289849
/post/tweet::1942253838402289849